Megan P. Hall, PhD is Vice President of Medical & Corporate Affairs, and a Distinguished Scientist, at GRAIL, Inc. Dr. Hall established and built GRAIL’s Medical Affairs group, supporting the development and launch of Galleri, the first blood-based multi-cancer early detection test.
Previously, Megan led Medical Communications for the hematology/oncology and chronic pain portfolios at Jazz Pharmaceuticals, established and built a medical communication team at Natera to support the launch and evolution of the Panorama non-invasive prenatal test, and was an editor at the flagship open access journal PLOS Biology.
Megan earned a BS in Biological Sciences from the University of California at Santa Barbara, and a PhD in Microbiology, Immunology, and Molecular Genetics from the University of California at Los Angeles. She has also held various research roles funded by the American Heart Association, California Institute of Regenerative Medicine, National Institutes of Health, and the Howard Hughes Research Foundation.